Effects of estrogen and opioid blockade on blood pressure reactivity to stress in postmenopausal women.

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA (1998) 24.54

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50

Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06

Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol Rev (2000) 8.13

The protective effects of estrogen on the cardiovascular system. N Engl J Med (1999) 6.25

Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension (2010) 4.62

Sex differences in HPA axis responses to stress: a review. Biol Psychol (2004) 3.75

Endogenous opioids: biology and function. Annu Rev Neurosci (1984) 2.54

Sex differences in pain and analgesia: the role of gonadal hormones. Eur J Pain (2004) 2.11

Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev (2000) 1.98

Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend (2004) 1.91

Stress-induced analgesia. Prog Neurobiol (2009) 1.78

Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health (1998) 1.78

Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry (2001) 1.63

Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation (1993) 1.61

Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol (1983) 1.54

Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol (2009) 1.39

Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab (1999) 1.21

Hemodynamic adjustments to laboratory stress: the influence of gender and personality. Psychosom Med (1994) 1.17

Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology (1989) 1.16

Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol (1992) 1.06

Age-related differences in cardiovascular reactivity during acute psychological stress in men and women. J Gerontol B Psychol Sci Soc Sci (1999) 1.01

Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med (1998) 0.95

Altered pituitary hormone response to naloxone in hypertension development. Hypertension (1989) 0.94

The role of sex and gender socialization in stress reactivity. Dev Psychol (2009) 0.93

Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. J Clin Invest (1984) 0.93

Sex differences in physiological responses to stress and in coronary heart disease: a causal link? Psychophysiology (1987) 0.92

Endogenous opioids modulate the cardiovascular response to mental stress. Psychoneuroendocrinology (1990) 0.88

Pathologic effect of estradiol on the hypothalamus. Biol Reprod (1993) 0.87

Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Brain Res (1987) 0.85

Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology (1990) 0.82

Stress and endogenous opioids: behavioral and circulatory interactions. Biol Psychol (1993) 0.81

Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women. Am J Physiol Heart Circ Physiol (2005) 0.81

Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. Am Heart J (2002) 0.80

Sex differences in cardiovascular reactivity: effects of the gender relevance of the stressor. Health Psychol (1991) 0.80

Relaxation training and opioid inhibition of blood pressure response to stress. J Consult Clin Psychol (1996) 0.80

Opioidergic inhibition of circulatory and endocrine stress responses in cynomolgus monkeys: a preliminary study. Psychosom Med (1993) 0.78

Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals. J Clin Endocrinol Metab (1982) 0.77

Sex differences in the hemodynamic responses to mental stress: Effect of caffeine consumption. Psychophysiology (2006) 0.77

Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sci (1986) 0.77

Inhibition of gonadotrophin release in mares during the luteal phase of the oestrous cycle by endogenous opioids. J Reprod Fertil (1993) 0.76

Lack of endogenous opioid inhibitory tone on LH secretion in early puberty. Clin Endocrinol (Oxf) (1984) 0.75

Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res (2005) 1.34

Expectations and placebo response: a laboratory investigation into the role of somatic focus. J Behav Med (2005) 1.25

Dispositional optimism predicts placebo analgesia. J Pain (2010) 1.17

The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: the effects of opioid blockade. Pain (2002) 1.10

Goal activation, expectations, and the placebo effect. J Pers Soc Psychol (2005) 1.06

Opioid analgesia in persons at risk for hypertension. Psychosom Med (2006) 1.05

Dispositional optimism and thoughts of well-being determine sensitivity to an experimental pain task. Ann Behav Med (2008) 1.04

Further evidence for individual differences in placebo responding: an interactionist perspective. J Psychosom Res (2007) 1.01

Why does choice enhance treatment effectiveness? Using placebo treatments to demonstrate the role of personal control. J Pers Soc Psychol (2013) 0.98

Social influence and pain response in women and men. J Behav Med (2008) 0.94

Placebo expectations and the detection of somatic information. J Behav Med (2010) 0.90

Post-traumatic stress disorder among patients with orofacial pain. J Orofac Pain (2005) 0.87

Elevated resting blood pressure and dampened emotional response. Psychosom Med (2004) 0.84

Prenatal maternal stress hormones, risk for hypertension, and the neonatal pain response: Comment on France et al., "Maternal family history of hypertension attenuates neonatal pain response". Pain (2009) 0.84

Language performance under sustained work and sleep deprivation conditions. Aviat Space Environ Med (2007) 0.81

Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. Am Heart J (2002) 0.80

Concept priming and pain: an experimental approach to understanding gender roles in sex-related pain differences. J Behav Med (2010) 0.80

Beliefs about expectations moderate the influence of expectations on pain perception. Int J Behav Med (2013) 0.76

Emotional dampening in persons with elevated blood pressure: affect dysregulation and risk for hypertension. Ann Behav Med (2014) 0.75

Prior experience with a pain stimulus as a predictor of placebo analgesia. J Behav Med (2014) 0.75